# Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B

> **NCT01429155** · — · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 36 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **GENETIC:** Interleukin 28B genotype

## Key facts

- **NCT ID:** NCT01429155
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429155, "Outcomes in Hepatitis C After Living Donor Liver Transplantation in Association With Interleukin 28 B". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01429155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*